28132082|t|High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury
28132082|a|Lung transplant recipients often develop acute kidney injury (AKI) evolving into chronic kidney disease (CKD). The immunosuppressant tacrolimus might be associated with the emergence of AKI. We analyzed the development and recovery of kidney injury after lung transplantation and related AKI to whole-blood tacrolimus trough concentrations and other factors causing kidney injury. We retrospectively studied kidney injury in 186 lung-transplantation patients at the UMC Utrecht between 2001 and 2011. Kidney function and whole-blood tacrolimus trough concentrations were determined from day 1 to 14 and at 1, 3, 6, and 12 months postoperative. Systemic inflammatory response syndrome (SIRS), septic shock, and nephrotoxic medications were evaluated as covariates for AKI. We analyzed liver injury and drug-drug interactions. AKI was present in 85 (46%) patients. Tacrolimus concentrations were supra-therapeutic in 135 of 186 patients (73%). AKI in the first week after transplantation was related to supra-therapeutic tacrolimus concentrations (OR 1.55; 95% CI 1.06-2.27), ≥3 other nephrotoxic drugs (OR 1.96; 95% CI 1.02-3.77), infection (OR 2.48; 95% CI 1.31-4.70), and cystic fibrosis (OR 2.17; 95% CI 1.16-4.06). Recovery rate of AKI was lower than expected (19%), and the cumulative incidence of severe CKD at 1 year was 15%. After lung transplantation, AKI is common and often evolves into severe CKD, which is a known cause of morbidity and mortality. Supra-therapeutic whole-blood tacrolimus trough concentrations are related to the early onset of AKI. Conscientious targeting tacrolimus blood concentrations might be vital in the early phase after lung transplantation. What is known about this subject? • Lung transplant recipients often develop acute kidney injury evolving into chronic kidney disease increasing both morbidity and mortality. • To date, the pathophysiology of kidney injury after lung transplantation has not been fully elucidated. • The immunosuppressant tacrolimus is difficult to dose, especially in the unstable clinical setting, and is nephrotoxic. • For the first time, supra-therapeutic whole-blood tacrolimus trough concentrations are related to the emergence of acute kidney injury in the first days after lung transplantation. • Supra-therapeutic whole-blood tacrolimus trough concentrations often occur early after lung transplantation. • AKI after lung transplantation shows low recovery rates.
28132082	5	15	tacrolimus	T103	UMLS:C0085149
28132082	49	69	lung transplantation	T058	UMLS:C0024128
28132082	86	99	kidney injury	T037	UMLS:C0160420
28132082	100	104	Lung	T017	UMLS:C0024109
28132082	141	160	acute kidney injury	T037	UMLS:C2609414
28132082	162	165	AKI	T037	UMLS:C2609414
28132082	181	203	chronic kidney disease	T038	UMLS:C1561643
28132082	205	208	CKD	T038	UMLS:C1561643
28132082	215	232	immunosuppressant	T103	UMLS:C0021081
28132082	233	243	tacrolimus	T103	UMLS:C0085149
28132082	286	289	AKI	T037	UMLS:C2609414
28132082	323	331	recovery	T038	UMLS:C2004454
28132082	335	348	kidney injury	T037	UMLS:C0160420
28132082	355	375	lung transplantation	T058	UMLS:C0024128
28132082	388	391	AKI	T037	UMLS:C2609414
28132082	395	406	whole-blood	T031	UMLS:C0370231
28132082	407	417	tacrolimus	T103	UMLS:C0085149
28132082	466	479	kidney injury	T037	UMLS:C0160420
28132082	484	507	retrospectively studied	T062	UMLS:C0035363
28132082	508	521	kidney injury	T037	UMLS:C0160420
28132082	529	549	lung-transplantation	T058	UMLS:C0024128
28132082	566	577	UMC Utrecht	T092	UMLS:C1708333
28132082	601	616	Kidney function	T038	UMLS:C0232804
28132082	621	632	whole-blood	T031	UMLS:C0370231
28132082	633	643	tacrolimus	T103	UMLS:C0085149
28132082	744	783	Systemic inflammatory response syndrome	T038	UMLS:C0242966
28132082	785	789	SIRS	T038	UMLS:C0242966
28132082	792	804	septic shock	T038	UMLS:C0036983
28132082	822	833	medications	T170	UMLS:C4284232
28132082	867	870	AKI	T037	UMLS:C2609414
28132082	884	896	liver injury	T037	UMLS:C0160390
28132082	901	923	drug-drug interactions	T038	UMLS:C0687133
28132082	925	928	AKI	T037	UMLS:C2609414
28132082	933	940	present	T033	UMLS:C0150312
28132082	963	973	Tacrolimus	T103	UMLS:C0085149
28132082	994	1011	supra-therapeutic	T033	UMLS:C4049341
28132082	1042	1045	AKI	T037	UMLS:C2609414
28132082	1070	1085	transplantation	T058	UMLS:C0024128
28132082	1101	1118	supra-therapeutic	T033	UMLS:C4049341
28132082	1119	1129	tacrolimus	T103	UMLS:C0085149
28132082	1183	1200	nephrotoxic drugs	T058	UMLS:C3687832
28132082	1230	1239	infection	T038	UMLS:C3714514
28132082	1273	1288	cystic fibrosis	T038	UMLS:C0010674
28132082	1335	1338	AKI	T037	UMLS:C2609414
28132082	1409	1412	CKD	T038	UMLS:C1561643
28132082	1438	1458	lung transplantation	T058	UMLS:C0024128
28132082	1460	1463	AKI	T037	UMLS:C2609414
28132082	1504	1507	CKD	T038	UMLS:C1561643
28132082	1560	1577	Supra-therapeutic	T033	UMLS:C4049341
28132082	1578	1589	whole-blood	T031	UMLS:C0370231
28132082	1590	1600	tacrolimus	T103	UMLS:C0085149
28132082	1657	1660	AKI	T037	UMLS:C2609414
28132082	1662	1675	Conscientious	T033	UMLS:C0580939
28132082	1686	1696	tacrolimus	T103	UMLS:C0085149
28132082	1758	1778	lung transplantation	T058	UMLS:C0024128
28132082	1816	1820	Lung	T017	UMLS:C0024109
28132082	1857	1876	acute kidney injury	T037	UMLS:C2609414
28132082	1891	1913	chronic kidney disease	T038	UMLS:C1561643
28132082	1989	2002	kidney injury	T037	UMLS:C0160420
28132082	2009	2029	lung transplantation	T058	UMLS:C0024128
28132082	2067	2084	immunosuppressant	T103	UMLS:C0021081
28132082	2085	2095	tacrolimus	T103	UMLS:C0085149
28132082	2136	2144	unstable	T033	UMLS:C0443343
28132082	2205	2222	supra-therapeutic	T033	UMLS:C4049341
28132082	2223	2234	whole-blood	T031	UMLS:C0370231
28132082	2235	2245	tacrolimus	T103	UMLS:C0085149
28132082	2300	2319	acute kidney injury	T037	UMLS:C2609414
28132082	2344	2364	lung transplantation	T058	UMLS:C0024128
28132082	2368	2385	Supra-therapeutic	T033	UMLS:C4049341
28132082	2386	2397	whole-blood	T031	UMLS:C0370231
28132082	2398	2408	tacrolimus	T103	UMLS:C0085149
28132082	2455	2475	lung transplantation	T058	UMLS:C0024128
28132082	2479	2482	AKI	T037	UMLS:C2609414
28132082	2489	2509	lung transplantation	T058	UMLS:C0024128
28132082	2520	2528	recovery	T038	UMLS:C2004454